283 related articles for article (PubMed ID: 16741573)
21. Discovery of potent liver-selective stearoyl-CoA desaturase-1 (SCD1) inhibitors, thiazole-4-acetic acid derivatives, for the treatment of diabetes, hepatic steatosis, and obesity.
Iida T; Ubukata M; Mitani I; Nakagawa Y; Maeda K; Imai H; Ogoshi Y; Hotta T; Sakata S; Sano R; Morinaga H; Negoro T; Oshida S; Tanaka M; Inaba T
Eur J Med Chem; 2018 Oct; 158():832-852. PubMed ID: 30248655
[TBL] [Abstract][Full Text] [Related]
22. Hepatic knockdown of stearoyl-CoA desaturase 1 via RNA interference in obese mice decreases lipid content and changes fatty acid composition.
Xu H; Wilcox D; Nguyen P; Voorbach M; Smith H; Brodjian S; Suhar T; Reilly RM; Jacobson PB; Collins CA; Landschulz K; Surowy TK
Front Biosci; 2007 May; 12():3781-94. PubMed ID: 17485339
[TBL] [Abstract][Full Text] [Related]
23. Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery.
Brown JM; Rudel LL
Curr Opin Lipidol; 2010 Jun; 21(3):192-7. PubMed ID: 20216310
[TBL] [Abstract][Full Text] [Related]
24. Adipose-specific deletion of stearoyl-CoA desaturase 1 up-regulates the glucose transporter GLUT1 in adipose tissue.
Hyun CK; Kim ED; Flowers MT; Liu X; Kim E; Strable M; Ntambi JM
Biochem Biophys Res Commun; 2010 Sep; 399(4):480-6. PubMed ID: 20655875
[TBL] [Abstract][Full Text] [Related]
25. SCD1 deficiency protects mice against ethanol-induced liver injury.
Lounis MA; Escoula Q; Veillette C; Bergeron KF; Ntambi JM; Mounier C
Biochim Biophys Acta; 2016 Nov; 1861(11):1662-1670. PubMed ID: 27477676
[TBL] [Abstract][Full Text] [Related]
26. Role of stearoyl-CoA desaturase-1 in skeletal muscle function and metabolism.
Stamatikos AD; Paton CM
Am J Physiol Endocrinol Metab; 2013 Oct; 305(7):E767-75. PubMed ID: 23941875
[TBL] [Abstract][Full Text] [Related]
27. Stearoyl-CoA Desaturase 1 (SCD1) is a key factor mediating diabetes in MyD88-deficient mice.
Yokoyama S; Hosoi T; Ozawa K
Gene; 2012 Apr; 497(2):340-3. PubMed ID: 22326531
[TBL] [Abstract][Full Text] [Related]
28. Stearoyl-CoA desaturase and insulin signaling--what is the molecular switch?
Dobrzyn P; Jazurek M; Dobrzyn A
Biochim Biophys Acta; 2010; 1797(6-7):1189-94. PubMed ID: 20153289
[TBL] [Abstract][Full Text] [Related]
29. Loss of stearoyl-CoA desaturase-1 improves insulin sensitivity in lean mice but worsens diabetes in leptin-deficient obese mice.
Flowers JB; Rabaglia ME; Schueler KL; Flowers MT; Lan H; Keller MP; Ntambi JM; Attie AD
Diabetes; 2007 May; 56(5):1228-39. PubMed ID: 17369521
[TBL] [Abstract][Full Text] [Related]
30. Leptin suppresses stearoyl-CoA desaturase 1 by mechanisms independent of insulin and sterol regulatory element-binding protein-1c.
Biddinger SB; Miyazaki M; Boucher J; Ntambi JM; Kahn CR
Diabetes; 2006 Jul; 55(7):2032-41. PubMed ID: 16804073
[TBL] [Abstract][Full Text] [Related]
31. Recent insights into stearoyl-CoA desaturase-1.
Ntambi JM; Miyazaki M
Curr Opin Lipidol; 2003 Jun; 14(3):255-61. PubMed ID: 12840656
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological inhibition of stearoyl-CoA desaturase 1 improves insulin sensitivity in insulin-resistant rat models.
Issandou M; Bouillot A; Brusq JM; Forest MC; Grillot D; Guillard R; Martin S; Michiels C; Sulpice T; Daugan A
Eur J Pharmacol; 2009 Sep; 618(1-3):28-36. PubMed ID: 19616540
[TBL] [Abstract][Full Text] [Related]
33. Combined therapy of dietary fish oil and stearoyl-CoA desaturase 1 inhibition prevents the metabolic syndrome and atherosclerosis.
Brown JM; Chung S; Sawyer JK; Degirolamo C; Alger HM; Nguyen TM; Zhu X; Duong MN; Brown AL; Lord C; Shah R; Davis MA; Kelley K; Wilson MD; Madenspacher J; Fessler MB; Parks JS; Rudel LL
Arterioscler Thromb Vasc Biol; 2010 Jan; 30(1):24-30. PubMed ID: 19834103
[TBL] [Abstract][Full Text] [Related]
34. Sterculic oil, a natural inhibitor of SCD1, improves the metabolic state of obese OLETF rats.
Ortinau LC; Nickelson KJ; Stromsdorfer KL; Naik CY; Pickering RT; Haynes RA; Fritsche KL; Perfield JW
Obesity (Silver Spring); 2013 Feb; 21(2):344-52. PubMed ID: 23404766
[TBL] [Abstract][Full Text] [Related]
35. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
[TBL] [Abstract][Full Text] [Related]
36. Skin-specific deletion of stearoyl-CoA desaturase-1 alters skin lipid composition and protects mice from high fat diet-induced obesity.
Sampath H; Flowers MT; Liu X; Paton CM; Sullivan R; Chu K; Zhao M; Ntambi JM
J Biol Chem; 2009 Jul; 284(30):19961-73. PubMed ID: 19429677
[TBL] [Abstract][Full Text] [Related]
37. Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells.
Iwai T; Kume S; Chin-Kanasaki M; Kuwagata S; Araki H; Takeda N; Sugaya T; Uzu T; Maegawa H; Araki SI
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834856
[TBL] [Abstract][Full Text] [Related]
38. Global deletion of lipocalin 2 does not reverse high-fat diet-induced obesity resistance in stearoyl-CoA desaturase-1 skin-specific knockout mice.
Friedlander NJ; Burhans MS; Ade L; O'Neill LM; Chen X; Ntambi JM
Biochem Biophys Res Commun; 2014 Mar; 445(3):578-83. PubMed ID: 24548407
[TBL] [Abstract][Full Text] [Related]
39. Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.
Geng T; Xia L; Russo S; Kamara D; Cowart LA
Nutr Res; 2015 Sep; 35(9):812-22. PubMed ID: 26277244
[TBL] [Abstract][Full Text] [Related]
40. [Stearoyl-CoA desaturase in the control of metabolic homeostasis].
Dobrzyń P
Postepy Biochem; 2012; 58(2):166-74. PubMed ID: 23214140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
